Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.63CAD
5:13pm BST
Change (% chg)

$-0.28 (-7.16%)
Prev Close
$3.91
Open
$3.97
Day's High
$3.97
Day's Low
$3.60
Volume
104,907
Avg. Vol
60,684
52-wk High
$4.50
52-wk Low
$1.11

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $782.96
Shares Outstanding(Mil.): 200.30
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 107.11 59.93
EPS (TTM): -0.79 -- --
ROI: -- 8.08 11.86
ROE: -- 8.26 12.88

Earnings vs. Estimates